Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2022 2
2023 2
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Heart rate variability and stroke or systemic embolism in patients with atrial fibrillation.
Hämmerle P, Aeschbacher S, Schlageter V, Coslovsky M, Hennings E, Krisai P, Coduri F, Blum MR, Rodondi N, Reichlin T, Müller A, Stauber A, Moschovitis G, Rigamonti E, Beer J, Ammann P, Bonati LH, Conen D, Osswald S, Kühne M, Zuern CS; Swiss-AF Investigators. Hämmerle P, et al. Heart Rhythm. 2024 Sep;21(9):1509-1516. doi: 10.1016/j.hrthm.2024.05.028. Epub 2024 May 16. Heart Rhythm. 2024. PMID: 38762133 Free article.
Physical activity and brain health in patients with atrial fibrillation.
Herber E, Aeschbacher S, Coslovsky M, Schwendinger F, Hennings E, Gasser A, Di Valentino M, Rigamonti E, Reichlin T, Rodondi N, Netzer S, Beer JH, Stauber A, Müller A, Ammann P, Sinnecker T, Duering M, Wuerfel J, Conen D, Kühne M, Osswald S, Bonati LH; SWISS-AF Investigators. Herber E, et al. Eur J Neurol. 2023 Mar;30(3):567-577. doi: 10.1111/ene.15660. Epub 2022 Dec 28. Eur J Neurol. 2023. PMID: 36478335 Free article.
Trimethylamine-N-oxide is associated with cardiovascular mortality and vascular brain lesions in patients with atrial fibrillation.
Luciani M, Müller D, Vanetta C, Diteepeng T, von Eckardstein A, Aeschbacher S, Rodondi N, Moschovitis G, Reichlin T, Sinnecker T, Wuerfel J, Bonati LH, Saeedi Saravi SS, Chocano-Bedoya P, Coslovsky M, Camici GG, Lüscher TF, Kuehne M, Osswald S, Conen D, Beer JH; SWISS-AF Investigators. Luciani M, et al. Heart. 2023 Feb 14;109(5):396-404. doi: 10.1136/heartjnl-2022-321300. Heart. 2023. PMID: 36593094 Clinical Trial.
Long-term risk of adverse outcomes according to atrial fibrillation type.
Blum S, Aeschbacher S, Coslovsky M, Meyre PB, Reddiess P, Ammann P, Erne P, Moschovitis G, Di Valentino M, Shah D, Schläpfer J, Müller R, Beer JH, Kobza R, Bonati LH, Moutzouri E, Rodondi N, Meyer-Zürn C, Kühne M, Sticherling C, Osswald S, Conen D; BEAT-AF and Swiss-AF investigators. Blum S, et al. Sci Rep. 2022 Feb 9;12(1):2208. doi: 10.1038/s41598-022-05688-9. Sci Rep. 2022. PMID: 35140237 Free PMC article.